LINC00362

Across TCGA pan-cancer cohorts, LINC00362 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC00362 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC00362 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00362 expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

MESO, UCS, and COAD are the cancer types where LINC00362 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
UCS	OS	Tertile	II,III,IV	0.068	0.631	<.001	108	view →
COAD	OS	Tertile	II,III,IV	0.140	0.850	<.001	54	view →
SKCM	DFS	Tertile	All	0.040	0.728	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.441	0.741	.010	36	view →
STAD	DFS	Tertile	All	0.506	0.671	.010	27	view →
ESCA	OS	Tertile	III,IV	1.000	0.372	.033	12	view →
SARC	OS	Tertile	All	0.677	0.862	.019	9	view →
BRCA	DFS	Tertile	III,IV	1.000	0.867	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC00362–MESO (OS)

Open the MESO breakdown →